Trigilio Jeffrey
Chief Financial Officer
2 companies
Insider Signal Score
51
AverageTrades Analyzed
12
12M Win Rate
16.7%
Avg 3M Return
-13.0%
Avg 12M Return
-42.8%
Trigilio Jeffrey is a Chief Financial Officer at Cullinan Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $4.3M based on current market prices.
Holdings by Company
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Financial Officer | Sell | 1,920 | $8.50 | $16,320.00 | -2.2% | +63.8% | +22.4% | |
| Dec 18, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Financial Officer | Sell | 398 | $8.22 | $3,271.56 | -0.5% | +67.8% | +25.8% | |
| Dec 12, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Financial Officer | Sell | 1,926 | $7.81 | $15,042.06 | -2.2% | +103.7% | +58.7% | |
| Jun 20, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Financial Officer | Sell | 399 | $12.94 | $5,163.06 | -0.5% | -23.1% | +34.0% | |
| Jun 12, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Financial Officer | Sell | 319 | $13.11 | $4,182.09 | -0.4% | -16.8% | +82.9% | |
| May 18, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Financial Officer | Sell | 399 | $8.76 | $3,495.24 | -0.5% | +13.9% | +163.3% | |
| May 12, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Financial Officer | Sell | 347 | $8.78 | $3,046.66 | -0.4% | +5.4% | +172.2% | |
| Apr 18, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Financial Officer | Sell | 398 | $10.71 | $4,262.58 | -0.5% | +10.3% | +74.1% | |
| Apr 12, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Financial Officer | Sell | 318 | $10.22 | $3,249.96 | -0.4% | +1.1% | +74.9% | |
| Mar 20, 2023 | CGEM Cullinan Therapeutics, Inc. | Chief Financial Officer | Sell | 399 | $11.32 | $4,516.68 | -0.5% | +20.1% | +42.5% |
Page 1Next →